Nutrient control of hunger by extrinsic gastrointestinal neurons

Trends in Endocrinology and Metabolism

Volumn 24, Issue 8, 2013, Pages 378-384

  Mithieux, Gilles ^a,b,c  

^a INSERM   (France)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITÉ DE LYON   (France)

Author keywords

Extrinsic gastrointestinal nerves; Macronutrients; Satiation; Satiety

Indexed keywords

GLUCOSE; LIPID; PROTEIN;

DIGESTION; ENERGY CONSUMPTION; EXTRINSIC GASTROINTESTINAL NERVOUS SYSTEM; FAT INTAKE; FOOD INTAKE; GLUCOSE HOMEOSTASIS; HUMAN; HUNGER; INTESTINE INNERVATION; NERVOUS SYSTEM; NUTRIENT UPTAKE; OBESITY; PRIORITY JOURNAL; PROTEIN INTAKE; REVIEW; SATIETY; SIGNAL TRANSDUCTION; STOMACH BYPASS; STOMACH INNERVATION;

EID: 84880935872     PISSN: 10432760     EISSN: 18793061     Source Type: Journal    
DOI: 10.1016/j.tem.2013.04.005     Document Type: Review

References (59)

1. Covasa M. Deficits in gastrointestinal responses controlling food intake and body weight. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2010, 299:R1423-R1439.
2. Little T.J., Feinle-Bisset C. Effects of dietary fat on appetite and energy intake in health and obesity - oral and gastrointestinal sensory contributions. Physiol. Behav. 2011, 104:613-620.
3. Yi C.X., et al. The role of the autonomic nervous liver innervation in the control of energy metabolism. Biochim. Biophys. Acta 2010, 1802:416-431.
4. Janssen P., et al. The role of gastric motility in the control of food intake. Aliment. Pharmacol. Ther. 2011, 33:880-894.
5. Date Y., et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002, 123:1120-1128.
6. Smith G.P., et al. Abdominal vagotomy blocks the satiety effect of cholecystokinin in the rat. Science 1981, 213:1036-1037.
7. Abbott C.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res. 2005, 1044:127-131.
8. Vahl T.P., et al. Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats. Endocrinology 2007, 148:4965-4973.
9. Breen D.M., et al. Gut-brain signalling: how lipids can trigger the gut. Diabetes Metab. Res. Rev. 2011, 27:113-119.
10. Rasmussen B.A., et al. Lipid sensing in the gut, brain and liver. Trends Endocrinol. Metab. 2012, 23:49-55.
11. Delaere F., et al. The role of sodium-coupled glucose co-transporter 3 in the satiety effect of portal glucose sensing. Mol. Metab. 2012, 2:47-53.
12. Duraffourd C., et al. Mu-opioid receptors and dietary protein stimulate a gut-brain neural circuitry limiting food intake. Cell 2012, 150:377-388.
13. Troy S., et al. Intestinal gluconeogenesis is a key factor for early metabolic changes after gastric bypass but not after gastric lap-band in mice. Cell Metab. 2008, 8:201-211.
14. Breen D.M., et al. Jejunal nutrient sensing is required for duodenal-jejunal bypass surgery to rapidly lower glucose concentrations in uncontrolled diabetes. Nat. Med. 2012, 18:950-955.
15. Wang P.Y., et al. Upper intestinal lipids trigger a gut-brain-liver axis to regulate glucose production. Nature 2008, 452:1012-1016.
16. Cheung G.W., et al. Intestinal cholecystokinin controls glucose production through a neuronal network. Cell Metab. 2009, 10:99-109.
17. Kokorovic A., et al. Duodenal mucosal protein kinase C-δ regulates glucose production in rats. Gastroenterology 2011, 141:1720-1727.
18. Breen D.M., et al. Duodenal PKC-δ and cholecystokinin signaling axis regulates glucose production. Diabetes 2011, 60:3148-3153.
19. Naville D., et al. Linik beetween intestinal CD36 ligand binding and satiety induced by a high protein diet in mice. PLoS ONE 2012, 7:e30686.
20. Schwartz G.J., et al. The lipid messenger OEA links dietary fat intake to satiety. Cell Metab. 2008, 8:281-288.
21. Tordoff M.G., Friedman M.I. Hepatic portal glucose infusions decrease food intake and increase food preference. Am. J. Physiol. 1986, 251:R192-R196.
22. Langhans W., et al. Intrameal hepatic-portal infusion of glucose reduces spontaneous meal size in rats. Physiol. Behav. 2001, 73:499-507.
23. Delaere F., et al. Hypothalamic integration of portal glucose signals and control of food intake and insulin sensitivity. Diabetes Metab. 2010, 36:257-262.
24. Mithieux G., et al. Portal sensing of intestinal gluconeogenesis is a mechanistic link in the diminution of food intake induced by diet protein. Cell Metab. 2005, 2:321-329.
25. Baird J.P., et al. Intake suppression after hepatic portal glucose infusion: all-or-none effect and its temporal threshold. Am. J. Physiol. 1997, 272:R1454-R1460.
26. Saberi M., et al. The locus for hypoglycemic detection shifts with the rate of fall in glycemia: the role of portal-superior mesenteric vein glucose sensing. Diabetes 2008, 57:1380-1386.
27. Thorens B., Larsen P.J. Gut-derived signaling molecules and vagal afferents in the control of glucose and energy homeostasis. Curr. Opin. Clin. Nutr. Metab. Care 2004, 7:471-478.
28. Janssen S., Depoortere I. Nutrient sensing in the gut: new roads to therapeutics?. Trends Endocrinol. Metab. 2013, 24:92-100.
29. Freeman S.L., et al. Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 8:532-539.
30. Berthoud H.E. Anatomy and function of sensory hepatic nerves. Anat. Rec. A: Discov. Mol. Cell. Evol. Biol. 2004, 280:827-835.
31. Chaveroux C., et al. Molecular mechanisms involved in the adaptation to amino acid limitation in mammals. Biochimie 2010, 92:736-745.
32. Anthony T.G., Gietzen D.W. Detection of amino acid deprivation in the central nervous system. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16:96-101.
33. Maurin A.C., et al. The GCN2 kinase biases feeding behavior to maintain amino acid homeostasis in omnivores. Cell Metab. 2005, 1:273-277.
34. Hao S., et al. Uncharged tRNA and sensing of amino acid deficiency in mammalian piriform cortex. Science 2005, 307:1776-1778.
35. Bellinger L.L., et al. Autonomic efferents affect intake of imbalanced amino acid diets by rats. Pharmacol. Biochem. Behav. 2005, 81:24-31.
36. L'Heureux-Bouron D., et al. A very high 70%-protein diet does not induce conditioned taste aversion in rats. J. Nutr. 2004, 134:1512-1515.
37. Pillot B., et al. Role of hypothalamic melanocortin system in adaptation of food intake to food protein increase in mice. PLoS ONE 2011, 6:1-7.
38. Mithieux G., et al. Intestinal gluconeogenesis: key signal of central control of energy and glucose homeostasis. Curr. Opin. Clin. Nutr. Metab. Care 2009, 12:419-423.
39. Penhoat A., et al. Protein-induced satiety is abolished in the absence of intestinal gluconeogenesis. Physiol. Behav. 2011, 105:89-93.
40. Berridge C.W. 'Liking' and 'wanting' food rewards: brain substrates and roles in eating disorders. Physiol. Behav. 2009, 97:537-550.
41. Berridge C.W., et al. Hypocretin/orexin in arousal and stress. Brain Res. 2010, 1314:91-102.
42. Zioudrou C., et al. Opioid peptides derived from food proteins. The exorphins. J. Biol. Chem. 1979, 254. 2446-1449.
43. Capasso A., et al. Design of mu selective opioid dipeptide antagonists. FEBS Lett. 1997, 417:141-144.
44. Moritoki H., et al. Tripeptides acting on opioid receptors in rat colon. Eur. J. Pharmacol. 1984, 100:29-39.
45. Schiller P., et al. Opioid dipeptide derivatives with a mixed μ antagonist/δ antagonist, partial μ agonist/δ antagonist or μ agonist/partial δ agonist profile. Am. Pept. Symp. 2002, 6:229-270.
46. Lee V.H. Membrane transporters. Eur. J. Pharm. Sci. 2000, 11(Suppl. 2):S41-S50.
47. Holzer P. Opioid receptors in the gastrointestinal tract. Regul. Pept. 2009, 155:11-17.
48. Thaler J.P., Cummings D.E. Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology 2009, 150:2518-2525.
49. Sala P.C., et al. Type 2 diabetes mellitus: a possible surgically reversible intestinal dysfunction. Obes. Surg. 2012, 22:167-176.
50. Perez-Tilve D., et al. A sweet spot for the bariatric surgeon. Cell Metab. 2008, 8:177-179.
51. Pillot B., et al. Protein feeding promotes redistribution of endogenous glucose production to the kidney and potentiates its suppression by insulin. Endocrinology 2009, 150:616-624.
52. Hayes M.T., et al. Is intestinal gluconeogenesis a key factor in the early changes in glucose homeostasis following gastric bypass?. Obes. Surg. 2011, 21:759-762.
53. Mithieux G. Comment about intestinal gluconeogenesis after gastric bypass in human in relation with the paper by Hayes et al., Obes. Surg. 2011. Obes. Surg. 2011, 22:1920-1922.
54. Mithieux G. A synergy between incretin effect and intestinal gluconeogenesis accounting for the rapid metabolic benefits of gastric bypass surgery. Curr. Diab. Rep. 2012, 12:167-171.
55. Warne J.P., Xu A.W. Metabolic transceivers: in tune with the central melanocortin system. Trends Endocrinol. Metab. 2013, 24:68-75.
56. Gibbs J., et al. Cholecystokinin-decreased food intake in rhesus monkeys. Am. J. Physiol. 1976, 230:15-18.
57. Rolls B.J., et al. The specificity of satiety: the influence of foods of different macronutrient content on the development of satiety. Physiol. Behav. 1988, 43:145-153.
58. Croset M., et al. Rat small intestine is an insulin-sensitive gluconeogenic organ. Diabetes 2001, 50:740-746.
59. Mithieux G., et al. A novel role for glucose 6-phosphatase in the small intestine in the control of glucose homeostasis. J. Biol. Chem. 2004, 279:44231-44234.